Xoc Pharmaceuticals is an early-stage, biopharmaceutical company focused on the development of innovative therapeutics. We design novel products “from the ground up” by leveraging information on existing compounds with established pharmacological and clinical history and utilizing the Company’s proprietary design and development process to address unmet medical needs, primarily in the CNS disease space.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
XC101-D13H for Migraine Prevention
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):